African babies are set to receive the R21 jab, a £3 malaria vaccine developed by a team at the University of Oxford that could potentially eradicate the disease within a decade. African babies are set to receive the R21 jab, a £3 malaria vaccine developed by a team at the University of Oxford that could potentially eradicate the disease within a decade.
Milestone in malaria battle as £3 vaccine is rolled out across Africa which could eradicate killer, mosquito-borne illness within 10 years
